Immune deficiency is a risk factor for severe COVID‐19 in people living with HIVChristian Hoffmann, Cristina Gervasoni, José L. Casado et al.|HIV Medicine|2020Cited by 166
Inter- and intra-patient variability of raltegravir pharmacokinetics in HIV-1-infected subjectsDario Cattaneo, Emilio Clementi, Cristina Gervasoni et al.|Journal of Antimicrobial Chemotherapy|2011Cited by 58
Low Body Weight in Females Is a Risk Factor for Increased Tenofovir Exposure and Drug-Related Adverse EventsCristina Gervasoni, Dario Cattaneo, Paola Meraviglia et al.|PLoS ONE|2013Cited by 42
Comparison of the <i>In Vivo</i> Pharmacokinetics and <i>In Vitro</i> Dissolution of Raltegravir in HIV Patients Receiving the Drug by Swallowing or by ChewingDario Cattaneo, Cristina Gervasoni, Sara Baldelli et al.|Antimicrobial Agents and Chemotherapy|2012Cited by 36
Second generation antipsychotics in ‘real-life’ paediatric patients. Adverse drug reactions and clinical outcomes of drug switchConcetta Rafaniello, Annalisa Capuano, Marco Pozzi et al.|Expert Opinion on Drug Safety|2016Cited by 33